{"id":112815,"date":"2025-03-14T16:20:51","date_gmt":"2025-03-14T12:20:51","guid":{"rendered":"https:\/\/noortrends.ae\/en\/?p=112815"},"modified":"2025-03-14T16:20:54","modified_gmt":"2025-03-14T12:20:54","slug":"bristol-myers-squibb-gains-expanded-eu-approval-for-car-t-therapy-breyanzi","status":"publish","type":"post","link":"https:\/\/noortrends.ae\/en\/bristol-myers-squibb-gains-expanded-eu-approval-for-car-t-therapy-breyanzi\/03\/14\/market-updates\/","title":{"rendered":"Bristol Myers Squibb Gains Expanded EU Approval for CAR-T Therapy Breyanzi"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\"><\/h3>\n\n\n\n<p>The <strong>European Commission<\/strong> has granted <strong>Bristol Myers Squibb (NYSE: BMY)<\/strong> an expanded approval for its <strong>CAR-T cell therapy, Breyanzi<\/strong>, the <strong>biopharmaceutical company<\/strong> announced on Friday.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Key Details of the Approval:<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>New Indication:<\/strong> Breyanzi is now approved for treating <strong>adults with relapsed or refractory follicular lymphoma<\/strong> who have undergone <strong>at least two prior systemic therapies<\/strong>.<\/li>\n\n\n\n<li><strong>Treatment Mechanism:<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Breyanzi<\/strong> is a <strong>CAR-T cell therapy<\/strong>, which involves <strong>genetically modifying a patient\u2019s immune cells<\/strong> to recognize and attack <strong>cancer cells<\/strong>.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Significance:<\/strong>\n<ul class=\"wp-block-list\">\n<li>The expanded approval <strong>broadens access<\/strong> to <strong>a cutting-edge treatment option<\/strong> for patients with <strong>limited alternatives<\/strong>.<\/li>\n\n\n\n<li>The decision follows <strong>clinical evidence demonstrating Breyanzi\u2019s efficacy<\/strong> in patients who <strong>did not respond to prior treatments or experienced relapse<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p>This approval reinforces <strong>Bristol Myers Squibb\u2019s leadership in the cell therapy space<\/strong>, potentially boosting its <strong>market presence in Europe<\/strong> while offering <strong>new hope for lymphoma patients<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Commission has granted Bristol Myers Squibb (NYSE: BMY) an expanded approval for its CAR-T cell therapy, Breyanzi, the biopharmaceutical company announced on Friday. Key Details of the Approval: New Indication: Breyanzi is now approved for treating adults with relapsed or refractory follicular lymphoma who have undergone at least two prior systemic therapies. Treatment &hellip;<\/p>\n","protected":false},"author":9,"featured_media":94439,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[38,36],"tags":[],"class_list":["post-112815","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-commodities-news","category-market-updates"],"_links":{"self":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/112815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/comments?post=112815"}],"version-history":[{"count":1,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/112815\/revisions"}],"predecessor-version":[{"id":112816,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/112815\/revisions\/112816"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media\/94439"}],"wp:attachment":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media?parent=112815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/categories?post=112815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/tags?post=112815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}